U.S. CDMRP – Arthritis Research Program (ATRP) | Research Funding
Event details
| Date | 16.10.2024 |
| Category | Call for proposal |
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the 2024 Arthritis Research Program (ATRP). Several award programs are available:
Funding:
Clinical Research Award: $1.5M – $3M
Focused Research Award: $500,000 – $750,000
Duration:
Clinical Research Award: 4 years
Focused Research Award: 2-3 years
Eligibility: Independent investigators at all academic levels (or equivalent) from international organizations or institutions are eligible to apply, and there are no citizenship restrictions.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace. Application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 16 October 2024, 5:00 p.m. Eastern time
Full Application Deadline: 30 October 2024, 11:59 p.m Eastern Time
Further information:
- The Clinical Research Award is intended to support clinical research that evaluates disease-specific factors and interventions. Research supported by this mechanism is intended to generate clinically useful evidence with potential to optimize patient outcomes and inform clinical care or policy. Research addressing all types of arthritis is encouraged including but not limited to osteoarthritis, post-traumatic arthritis, inflammatory arthritis, juvenile arthritis, or rheumatoid arthritis. The ATRP encourages applications that address sex as a biological variable and understudied arthritis types. The ATRP also encourages applicants to consider whether large data sets or existing studies/consortia can be leveraged to maximize the potential impact of the proposed research. All applications must specifically address Focus Areas listed in this document.
- The Focused Research Award is intended to support conceptually innovative, high-risk/potentially highreward research that could ultimately lead to critical discoveries and/or improvements in patient care or quality of life for people impacted by arthritis. Research addressing all types of arthritis is encouraged including but not limited to osteoarthritis, post-traumatic arthritis, inflammatory arthritis, juvenile arthritis, and rheumatoid arthritis. The ATRP encourages applications that address sex as a biological variable and understudied arthritis types. The ATRP also encourages applicants to consider whether large data sets or existing studies/consortia can be leveraged to maximize the potential impact of proposed studies. All applications must specifically address Focus Areas listed in this document.
Funding:
Clinical Research Award: $1.5M – $3M
Focused Research Award: $500,000 – $750,000
Duration:
Clinical Research Award: 4 years
Focused Research Award: 2-3 years
Eligibility: Independent investigators at all academic levels (or equivalent) from international organizations or institutions are eligible to apply, and there are no citizenship restrictions.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace. Application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 16 October 2024, 5:00 p.m. Eastern time
Full Application Deadline: 30 October 2024, 11:59 p.m Eastern Time
Further information:
- To find the full program announcements and to start your pre-application see here
- A useful summary of each call can be found here
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
- Grants.gov Funding Opportunity Numbers:
- Clinical Research Award: HT942524ATRPCRA
- Focused Research Award: HT942524ATRPFRA
Practical information
- Informed public
- Free